Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07230483
PHASE2

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Sponsor: Keymed Biosciences Co.Ltd

View on ClinicalTrials.gov

Summary

This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.

Official title: An Open-Label, Multicenter Study to Evaluate Long-Term Safety and Efficacy of CM512 in Atopic Dermatitis Patients.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

246

Start Date

2025-12

Completion Date

2027-12

Last Updated

2025-11-17

Healthy Volunteers

No

Interventions

BIOLOGICAL

CM512

CM512 subcutaneous injection

Locations (1)

Peking University People's Hospital

Beijing, Beijing Municipality, China